Yvonne Paterson
Affiliations: | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Immunology, Microbiology BiologyGoogle:
"Yvonne Paterson"Children
Sign in to add trainee| George R. Gunn | grad student | 2001 | Penn |
| Amy E. Matthews | grad student | 2001 | Penn |
| Ross S. Johnson | grad student | 2003 | Penn |
| Reshma Singh | grad student | 2006 | Penn |
| Nicholas C. Souders | grad student | 2006 | Penn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oladejo M, Paterson Y, Wood LM. (2021) Clinical Experience and Recent Advances in the Development of -Based Tumor Immunotherapies. Frontiers in Immunology. 12: 642316 |
| Ghouse SM, Vadrevu SK, Manne S, et al. (2020) Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis. Journal of Immunology (Baltimore, Md. : 1950) |
| Markiewski MM, Vadrevu SK, Sharma SK, et al. (2017) The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1. Journal of Immunology (Baltimore, Md. : 1950) |
| Hernández-Flores KG, Calderón-Garcidueñas AL, Mellado-Sánchez G, et al. (2016) Evaluation of the safety and adjuvant effect of a detoxified Listeriolysin O mutant on the humoral response to Dengue virus antigens. Clinical and Experimental Immunology |
| Stroud C, Dmitriev I, Kashentseva E, et al. (2016) A One Health overview, facilitating advances in comparative medicine and translational research. Clinical and Translational Medicine. 5: 26 |
| Mason N, Gnanandarajah J, Engiles J, et al. (2016) Immunotherapy with a HER2 targeted Listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase I trial in canine osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Bui CT, Shollenberger LM, Paterson Y, et al. (2015) Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope. Clinical and Vaccine Immunology : Cvi. 22: 193-9 |
| Mason N, Gnanandarajah J, Laughlin D, et al. (2015) Abstract LB-113: Recombinant HER2/Neu expressing Listeria combined with radiation safely delays tumor progression and prolongs overall survival in a phase I clinical study in canine osteosarcoma Cancer Research. 75 |
| Bui CT, Shollenberger LM, Paterson Y, et al. (2014) Schistosoma mansoni soluble egg antigens enhance Listeria monocytogenes vector HIV-1 vaccine induction of cytotoxic T cells. Clinical and Vaccine Immunology : Cvi. 21: 1232-9 |
| Wood LM, Paterson Y. (2014) Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy. Frontiers in Cellular and Infection Microbiology. 4: 51 |